Details for New Drug Application (NDA): 020579
✉ Email this page to a colleague
The generic ingredient in FLOMAX is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.
Summary for 020579
Tradename: | FLOMAX |
Applicant: | Sanofi |
Ingredient: | tamsulosin hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 020579
Mechanism of Action | Adrenergic alpha-Antagonists |
Suppliers and Packaging for NDA: 020579
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579 | NDA | sanofi-aventis U.S. LLC | 0024-5837 | 0024-5837-01 | 100 CAPSULE in 1 BOTTLE (0024-5837-01) |
FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579 | NDA | RedPharm Drug, Inc. | 67296-1803 | 67296-1803-3 | 30 CAPSULE in 1 BOTTLE (67296-1803-3) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.4MG | ||||
Approval Date: | Apr 15, 1997 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020579
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi | FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579-001 | Apr 15, 1997 | ⤷ Subscribe | ⤷ Subscribe |
Sanofi | FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579-001 | Apr 15, 1997 | ⤷ Subscribe | ⤷ Subscribe |
Sanofi | FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579-001 | Apr 15, 1997 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription